CGM use in on the rise. Pharmacists can play an important role in educating people with diabetes about CGM, interpreting CGM data, and making evidence-based therapeutic recommendations based on CGM data. This live webinar will provide an update on current CGM technologies and offer discussions related to CGM data interpretation, patient education, and reimbursement and insurance coverage considerations. Developed in collaboration with APhA, ADCES, JDRF, and Med-IQ.

Get a crash course in the pharmacology and pathophysiology of diabetes.

Dive into motivational interviewing (MI) and build the person-centered skills required to facilitate effective individual and group conversations around goal-setting and behavior change for participants in national diabetes prevention program (DPP) lifestyle change programs.

Register now for the first virtual ADCES annual conference!

Get a crash course in the pharmacology and pathophysiology of diabetes.

Acquire the necessary skills to deliver a successful National Diabetes Prevention Program (DPP) at your site.

Participate in a Lifestyle Coach Training (LSC) to acquire the necessary skills to deliver a successful National Diabetes Prevention Program (DPP) at your site.

The 2019 Medicare and You Handbook includes information on the Medicare Diabetes Prevention Program, a new Medicare-covered service. Help your patients prevent or delay Type 2 diabetes and understand their treatment options. During this call, learn about the service, eligibility requirements, and how to refer your patients. A question and answer session follows the presentation.

Join HealthInsight for their webinar on engaging Latino/x populations.

This Diabetes Prevention Program webinar series will examine health care organizations’ experiences developing and implementing protocols for screening, testing, and referring patients with prediabetes to a CDC-recognized type 2 diabetes prevention program. The webinars will be moderated by ACPM faculty member Heather Tindall Readhead, MD, MPH.

This Diabetes Prevention Program webinar series will examine health care organizations’ experiences developing and implementing protocols for screening, testing, and referring patients with prediabetes to a CDC-recognized type 2 diabetes prevention program. The webinars will be moderated by ACPM faculty member Heather Tindall Readhead, MD, MPH.

This Diabetes Prevention Program webinar series will examine health care organizations’ experiences developing and implementing protocols for screening, testing, and referring patients with prediabetes to a CDC-recognized type 2 diabetes prevention program. The webinars will be moderated by ACPM faculty member Heather Tindall Readhead, MD, MPH.

During this call, find out about the Medicare Diabetes Prevention Program (MDPP), the processes organizations and health care providers must go through to enroll as MDPP suppliers, and how to bill for services. A question and answer session follows the presentation.

This webinar will focus on specific steps that employers and commercial health plans can take to effectively establish coverage for the National DPP lifestyle change program. It will include a brief overview of the CDC-led National DPP and its impact nationwide.

Join Healthy People 2020 and the Diabetes Advocacy Alliance on Wednesday, June 13 at 12:00 p.m. ET for a Spotlight on Health webinar about diabetes prevention programs (DPPs) and new payment options.

Every year, on May 31st, WHO and its partners, including the World Heart Federation (WHF), mark World No Tobacco Day to highlight the health and other risks associated with tobacco use and advocate for effective policies to reduce tobacco consumption.

The purpose of Men’s Health Month is to heighten the awareness of preventable health problems and encourage early detection and treatment of disease among men and boys.

Participate in a Lifestyle Coach Training (LSC) to acquire the necessary skills to deliver a successful National Diabetes Prevention Program (DPP) at your site.

This webinar will review the key hormones for glucose homeostasis and then focus on the incretin hormone GLP-1. The actions of GLP-1 will be covered in both normal physiology and the pathophysiology of type 2 diabetes. Finally, there will be an overview of key clinical and safety data of approved GLP-1 receptor agonists.